Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Recombinant Human Thrombopoietin(rhTPO), developed by Shenyang Sansheng Pharmaceutical Co., Ltd., was approved for marketing in China in 2005 and used to treat thrombocytopenia caused by chemotherapy. It was approved for the treatment of immune thrombocytopenia (ITP) in 2010. In 2017, it was included in the National Medical Insurance Drug List of Western Medicine Partial Medical Insurance Category B. By 2020, Shenyang Sansheng Pharmaceutical Co., Ltd. is the only manufacturer in China's rhTPO market.
According to CRI's market research, the sales value of rhTPO in the Chinese market has increased year by year from 2016 to 2020. In 2020, due to the impact of the COVID-19 epidemic on the overall diagnosis and treatment services of hospitals in China, its sales growth has slowed, but the sales value of rhTPO in the Chinese market still reached CNY1.3 billion, and the CAGR was 32.44% in 2016 to 2020.
CRI expects that with the effective relief of the COVID-19 epidemic in 2021-2025, the sales of rhTPO will increase. In addition, the cancer incidence rate in China has maintained an annual increase of about 3.9% in the past 10 years. Therefore, the sales volume of rhTPO used to treat cancer and other chemotherapy-induced thrombocytopenia will increase with the increase in the number of cancer patients. At the same time, TPIAO’s patent has expired, and many companies in China have applied for approval for clinical trials of generic drugs. It is expected that new manufacturers will join the rhTPO market in the next five years, and sales will grow in the future.
Topics Covered:
-The impact of COVID-19 on China's Recombinant Human Thrombopoietin(rhTPO) market
- Sales value of China's Recombinant Human Thrombopoietin(rhTPO) 2016-2020
- Competitive landscape of China's Recombinant Human Thrombopoietin(rhTPO) market
- Prices of Recombinant Human Thrombopoietin(rhTPO) in China
- Prices of Recombinant Human Thrombopoietin(rhTPO) in China by regions and manufacturers
- Analysis on factors affecting the development of China's Recombinant Human Thrombopoietin(rhTPO) market
- Prospect of China's Recombinant Human Thrombopoietin(rhTPO) market from 2021 to 2025
According to CRI's market research, the sales value of rhTPO in the Chinese market has increased year by year from 2016 to 2020. In 2020, due to the impact of the COVID-19 epidemic on the overall diagnosis and treatment services of hospitals in China, its sales growth has slowed, but the sales value of rhTPO in the Chinese market still reached CNY1.3 billion, and the CAGR was 32.44% in 2016 to 2020.
CRI expects that with the effective relief of the COVID-19 epidemic in 2021-2025, the sales of rhTPO will increase. In addition, the cancer incidence rate in China has maintained an annual increase of about 3.9% in the past 10 years. Therefore, the sales volume of rhTPO used to treat cancer and other chemotherapy-induced thrombocytopenia will increase with the increase in the number of cancer patients. At the same time, TPIAO’s patent has expired, and many companies in China have applied for approval for clinical trials of generic drugs. It is expected that new manufacturers will join the rhTPO market in the next five years, and sales will grow in the future.
Topics Covered:
-The impact of COVID-19 on China's Recombinant Human Thrombopoietin(rhTPO) market
- Sales value of China's Recombinant Human Thrombopoietin(rhTPO) 2016-2020
- Competitive landscape of China's Recombinant Human Thrombopoietin(rhTPO) market
- Prices of Recombinant Human Thrombopoietin(rhTPO) in China
- Prices of Recombinant Human Thrombopoietin(rhTPO) in China by regions and manufacturers
- Analysis on factors affecting the development of China's Recombinant Human Thrombopoietin(rhTPO) market
- Prospect of China's Recombinant Human Thrombopoietin(rhTPO) market from 2021 to 2025
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
